LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	PD0325901	0.04	uM	LJP5	72	hr	1097	2970	3769	0.7881	0.7011
BT-20	PD0325901	0.04	uM	LJP6	72	hr	1097	3326	3769	0.8825	0.8343
BT-20	PD173074	0.04	uM	LJP6	72	hr	1097	3941	3769	1.0457	1.0644
BT-20	PD184352	0.04	uM	LJP5	72	hr	1097	4128	3769	1.0952	1.1343
BT-20	Pelitinib	0.04	uM	LJP5	72	hr	1097	3481	3769	0.9235	0.8922
BT-20	PF431396	0.04	uM	LJP5	72	hr	1097	3635	3769	0.9643	0.9497
BT-20	PF477736	0.04	uM	LJP5	72	hr	1097	3562	3769	0.9450	0.9225
BT-20	PF562271	0.04	uM	LJP6	72	hr	1097	3406	3769	0.9036	0.8640
BT-20	PHA-665752	0.04	uM	LJP5	72	hr	1097	3938	3769	1.0447	1.0630
BT-20	PHA-793887	0.04	uM	LJP6	72	hr	1097	2523	3769	0.6694	0.5337
BT-20	PI103	0.04	uM	LJP6	72	hr	1097	3215	3769	0.8531	0.7927
BT-20	PLX-4720	0.04	uM	LJP5	72	hr	1097	3773	3769	1.0010	1.0014
BT-20	QL-X-138	0.04	uM	LJP6	72	hr	1097	2930	3769	0.7773	0.6858
BT-20	QL-XII-47	0.04	uM	LJP6	72	hr	1097	1829	3769	0.4853	0.2740
BT-20	Radicicol	0.04	uM	LJP5	72	hr	1097	3196	3769	0.8479	0.7855
BT-20	Radicicol	0.04	uM	LJP6	72	hr	1097	2856	3769	0.7577	0.6583
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1097	3909	3769	1.0370	1.0522
BT-20	Ruxolitinib	0.04	uM	LJP5	72	hr	1097	3687	3769	0.9782	0.9692
BT-20	XL147	0.04	uM	LJP5	72	hr	1097	4302	3769	1.1413	1.1993
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1097	3499	3769	0.9284	0.8990
BT-20	Selumetinib	0.04	uM	LJP6	72	hr	1097	3709	3769	0.9840	0.9775
BT-20	Sirolimus	0.04	uM	LJP6	72	hr	1097	2367	3769	0.6280	0.4753
BT-20	Sorafenib	0.04	uM	LJP6	72	hr	1097	3411	3769	0.9051	0.8661
BT-20	SU11274	0.04	uM	LJP5	72	hr	1097	4164	3769	1.1048	1.1479
BT-20	Fedratinib	0.04	uM	LJP5	72	hr	1097	4106	3769	1.0894	1.1262

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)